Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges
Lung cancer, a highly prevalent and deadly malignancy globally, poses a significant disease burden in China and is the leading cause of cancer death. Despite rapid advances in medicine, its incidence and mortality rates remain stubbornly high, making it a major challenge in public health. Against th...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | zho |
| Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2025-03-01
|
| Series: | Chinese Journal of Lung Cancer |
| Subjects: | |
| Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2025.106.07 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850187485856923648 |
|---|---|
| author | Pengxu KONG Xiaohan CHEN Wang LV Pinghui XIA Luming WANG Jian HU |
| author_facet | Pengxu KONG Xiaohan CHEN Wang LV Pinghui XIA Luming WANG Jian HU |
| author_sort | Pengxu KONG |
| collection | DOAJ |
| description | Lung cancer, a highly prevalent and deadly malignancy globally, poses a significant disease burden in China and is the leading cause of cancer death. Despite rapid advances in medicine, its incidence and mortality rates remain stubbornly high, making it a major challenge in public health. Against the backdrop of rapid progress in precision medicine, the paradigm of lung cancer treatment is shifting from single traditional therapy to multi-dimensional integration. This article comprehensively reviews the innovations and challenges in lung cancer surgery in 2024, aiming to explore the future development of surgical treatment with colleagues and to improve patients' quality of life and achieve the goal of "cure". |
| format | Article |
| id | doaj-art-e154b7be08b6444593cd5e559ae78752 |
| institution | OA Journals |
| issn | 1009-3419 1999-6187 |
| language | zho |
| publishDate | 2025-03-01 |
| publisher | Chinese Anti-Cancer Association; Chinese Antituberculosis Association |
| record_format | Article |
| series | Chinese Journal of Lung Cancer |
| spelling | doaj-art-e154b7be08b6444593cd5e559ae787522025-08-20T02:16:05ZzhoChinese Anti-Cancer Association; Chinese Antituberculosis AssociationChinese Journal of Lung Cancer1009-34191999-61872025-03-0128319520010.3779/j.issn.1009-3419.2025.106.07Surgical Perspective on Lung Cancer in 2024: Innovation and ChallengesPengxu KONG0Xiaohan CHEN1Wang LV2Pinghui XIA3Luming WANG4Jian HU5Department of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Key Laboratory of Clinical Evaluation Technology for Medical Device, Hangzhou 310003, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Key Laboratory of Clinical Evaluation Technology for Medical Device, Hangzhou 310003, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Key Laboratory of Clinical Evaluation Technology for Medical Device, Hangzhou 310003, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Key Laboratory of Clinical Evaluation Technology for Medical Device, Hangzhou 310003, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Key Laboratory of Clinical Evaluation Technology for Medical Device, Hangzhou 310003, ChinaDepartment of Thoracic Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang Key Laboratory of Clinical Evaluation Technology for Medical Device, Hangzhou 310003, ChinaLung cancer, a highly prevalent and deadly malignancy globally, poses a significant disease burden in China and is the leading cause of cancer death. Despite rapid advances in medicine, its incidence and mortality rates remain stubbornly high, making it a major challenge in public health. Against the backdrop of rapid progress in precision medicine, the paradigm of lung cancer treatment is shifting from single traditional therapy to multi-dimensional integration. This article comprehensively reviews the innovations and challenges in lung cancer surgery in 2024, aiming to explore the future development of surgical treatment with colleagues and to improve patients' quality of life and achieve the goal of "cure".http://dx.doi.org/10.3779/j.issn.1009-3419.2025.106.07lung neoplasmssurgeryinnovative advancementssurgical approacheslife-cycle managementperioperative therapy |
| spellingShingle | Pengxu KONG Xiaohan CHEN Wang LV Pinghui XIA Luming WANG Jian HU Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges Chinese Journal of Lung Cancer lung neoplasms surgery innovative advancements surgical approaches life-cycle management perioperative therapy |
| title | Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges |
| title_full | Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges |
| title_fullStr | Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges |
| title_full_unstemmed | Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges |
| title_short | Surgical Perspective on Lung Cancer in 2024: Innovation and Challenges |
| title_sort | surgical perspective on lung cancer in 2024 innovation and challenges |
| topic | lung neoplasms surgery innovative advancements surgical approaches life-cycle management perioperative therapy |
| url | http://dx.doi.org/10.3779/j.issn.1009-3419.2025.106.07 |
| work_keys_str_mv | AT pengxukong surgicalperspectiveonlungcancerin2024innovationandchallenges AT xiaohanchen surgicalperspectiveonlungcancerin2024innovationandchallenges AT wanglv surgicalperspectiveonlungcancerin2024innovationandchallenges AT pinghuixia surgicalperspectiveonlungcancerin2024innovationandchallenges AT lumingwang surgicalperspectiveonlungcancerin2024innovationandchallenges AT jianhu surgicalperspectiveonlungcancerin2024innovationandchallenges |